As part of FDA ’ s crucial role in facilitating medical countermeasures to treat & prevent #COVID19, we are working with government, academic & industry partners to facilitate the development of, & access to, investigational therapies made from human blood. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-coordinates-national-effort-develop-blood-related-therapies-covid-19   … pic.twitter.com/0rpKjmvlz6

As part of FDA’s crucial role in facilitating medical countermeasures to treat & prevent #COVID19, we are working with government, academic & industry partners to facilitate the development of, & access to, investigational therapies made from human blood. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-coordinates-national-effort-develop-blood-related-therapies-covid-19 … pic.twitter.com/0rpKjmvlz6

Source: Food and Drug Adminstration (FDA): CDRHNew - April 3, 2020 Category: Medical Devices Authors: ( at SteveFDA) Source Type: news